1:22 PM
 | 
Jun 13, 2017
 |  BC Innovations  |  Distillery Therapeutics

Infectious disease

INDICATION: Hepatitis C virus (HCV)

Cell culture studies suggest inhibiting ERN1 could help treat HCV infection. In HCV patients, levels of ERN1 activity in the liver were higher than in HCV-negative liver transplant...

Read the full 143 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Innovations

Article Purchase

$18 USD
More Info >